Cargando…

Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data

BACKGROUND: Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Beretta, Lorenzo, Santaniello, Alessandro, van Riel, Piet LCM, Coenen, Marieke JH, Scorza, Raffaella
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928804/
https://www.ncbi.nlm.nih.gov/pubmed/20691091
http://dx.doi.org/10.1186/1471-2105-11-416
_version_ 1782185890698756096
author Beretta, Lorenzo
Santaniello, Alessandro
van Riel, Piet LCM
Coenen, Marieke JH
Scorza, Raffaella
author_facet Beretta, Lorenzo
Santaniello, Alessandro
van Riel, Piet LCM
Coenen, Marieke JH
Scorza, Raffaella
author_sort Beretta, Lorenzo
collection PubMed
description BACKGROUND: Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets. RESULTS: The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals. CONCLUSIONS: Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data. Availability: http://sourceforge.net/projects/sdrproject/
format Text
id pubmed-2928804
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29288042010-08-27 Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data Beretta, Lorenzo Santaniello, Alessandro van Riel, Piet LCM Coenen, Marieke JH Scorza, Raffaella BMC Bioinformatics Research Article BACKGROUND: Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets. RESULTS: The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals. CONCLUSIONS: Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data. Availability: http://sourceforge.net/projects/sdrproject/ BioMed Central 2010-08-06 /pmc/articles/PMC2928804/ /pubmed/20691091 http://dx.doi.org/10.1186/1471-2105-11-416 Text en Copyright ©2010 Beretta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Beretta, Lorenzo
Santaniello, Alessandro
van Riel, Piet LCM
Coenen, Marieke JH
Scorza, Raffaella
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_full Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_fullStr Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_full_unstemmed Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_short Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
title_sort survival dimensionality reduction (sdr): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928804/
https://www.ncbi.nlm.nih.gov/pubmed/20691091
http://dx.doi.org/10.1186/1471-2105-11-416
work_keys_str_mv AT berettalorenzo survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT santanielloalessandro survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT vanrielpietlcm survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT coenenmariekejh survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata
AT scorzaraffaella survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata